LIFECORE BIOMEDICAL, INC. (LFCR) Net margin 2016–2025
LIFECORE BIOMEDICAL, INC. (LFCR) net profit margin by fiscal year — reported net income divided by reported revenue.
-30.0%FY2025 · since FY2016: -2.4% → -30.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -30.0% | -39.4 pp |
| FY2024 | 9.4% | +105.8 pp |
| FY2023 | -96.4% | +8.4 pp |
| FY2022 | -104.9% | -72.9 pp |
| FY2021 | -32.0% | -8.2 pp |
| FY2020 | -23.9% | -23.9 pp |
| FY2019 | 0.1% | -4.7 pp |
| FY2018 | 4.7% | +2.5 pp |
| FY2017 | 2.3% | +4.7 pp |
| FY2016 | -2.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice